Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Carr

Showing results (521-530 of 545) with videos related to

Pageof 55
Sort By:
JAMA Surgery|August 9, 2023
Association of Transport Time, Proximity, and Emergency Department Pediatric Readiness With Pediatric Survival at US Trauma CentersNina E Glass, Apoorva Salvi, Ran Wei, et al.
Cancer Genetics|November 7, 2020
Lack of pathogenic germline DICER1 variants in males with testicular germ-cell tumorsLauren M Vasta, Mary L McMaster, Laura A Harney, et al.
Journal of Medicinal Chemistry|January 22, 2005
Identification of novel p38alpha MAP kinase inhibitors using fragment-based lead generationAdrian L Gill, Martyn Frederickson, Anne Cleasby, et al.
British Journal of Pharmacology|March 11, 2021
Halofuginone, a promising drug for treatment of pulmonary hypertensionPritesh P Jain, Tengteng Zhao, Mingmei Xiong, et al.
Thorax|March 20, 2024
Prevalence of lung cysts in adolescents and adults with a germline <i>DICER1</i> pathogenic/likely pathogenic variant: a report from the National Institutes of Health and International Pleuropulmonary Blastoma/<i>DICER1</i> RegistryAlexander T Nelson, Lauren M Vasta, Dave Watson, et al.
Bioorganic & Medicinal Chemistry Letters|February 24, 2001
The identification of alpha-ketoamides as potent inhibitors of hepatitis C virus NS3-4A proteinaseJ M Bennett, A D Campbell, A J Campbell, et al.
Journal of Medicinal Chemistry|October 27, 2021
Fragment-Guided Discovery of Pyrazole Carboxylic Acid Inhibitors of the Kelch-like ECH-Associated Protein 1: Nuclear Factor Erythroid 2 Related Factor 2 (KEAP1:NRF2) Protein-Protein InteractionDavid Norton, William G Bonnette, James F Callahan, et al.
The Journal of Clinical Endocrinology and Metabolism|March 22, 2017
Quantification of Thyroid Cancer and Multinodular Goiter Risk in the DICER1 Syndrome: A Family-Based Cohort StudyNicholas E Khan, Andrew J Bauer, Kris Ann P Schultz, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|September 29, 2025
2025 SCAI Clinical Practice Guidelines for the Management of Chronic Venous Disease: This statement was endorsed by the Society for Vascular Medicine (SVM)Robert R Attaran, Matthew L Edwards, Frank J Arena, et al.
JAMA Network Open|February 25, 2021
A Genome-First Approach to Characterize DICER1 Pathogenic Variant Prevalence, Penetrance, and PhenotypeUyenlinh L Mirshahi, Jung Kim, Ana F Best, et al.
Pageof 55

Showing results (521-530 of 545) with videos related to

Sort By:
Pageof 55
JAMA Surgery|August 9, 2023
Association of Transport Time, Proximity, and Emergency Department Pediatric Readiness With Pediatric Survival at US Trauma CentersNina E Glass, Apoorva Salvi, Ran Wei, et al.
Cancer Genetics|November 7, 2020
Lack of pathogenic germline DICER1 variants in males with testicular germ-cell tumorsLauren M Vasta, Mary L McMaster, Laura A Harney, et al.
Journal of Medicinal Chemistry|January 22, 2005
Identification of novel p38alpha MAP kinase inhibitors using fragment-based lead generationAdrian L Gill, Martyn Frederickson, Anne Cleasby, et al.
British Journal of Pharmacology|March 11, 2021
Halofuginone, a promising drug for treatment of pulmonary hypertensionPritesh P Jain, Tengteng Zhao, Mingmei Xiong, et al.
Thorax|March 20, 2024
Prevalence of lung cysts in adolescents and adults with a germline <i>DICER1</i> pathogenic/likely pathogenic variant: a report from the National Institutes of Health and International Pleuropulmonary Blastoma/<i>DICER1</i> RegistryAlexander T Nelson, Lauren M Vasta, Dave Watson, et al.
Bioorganic & Medicinal Chemistry Letters|February 24, 2001
The identification of alpha-ketoamides as potent inhibitors of hepatitis C virus NS3-4A proteinaseJ M Bennett, A D Campbell, A J Campbell, et al.
Journal of Medicinal Chemistry|October 27, 2021
Fragment-Guided Discovery of Pyrazole Carboxylic Acid Inhibitors of the Kelch-like ECH-Associated Protein 1: Nuclear Factor Erythroid 2 Related Factor 2 (KEAP1:NRF2) Protein-Protein InteractionDavid Norton, William G Bonnette, James F Callahan, et al.
The Journal of Clinical Endocrinology and Metabolism|March 22, 2017
Quantification of Thyroid Cancer and Multinodular Goiter Risk in the DICER1 Syndrome: A Family-Based Cohort StudyNicholas E Khan, Andrew J Bauer, Kris Ann P Schultz, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|September 29, 2025
2025 SCAI Clinical Practice Guidelines for the Management of Chronic Venous Disease: This statement was endorsed by the Society for Vascular Medicine (SVM)Robert R Attaran, Matthew L Edwards, Frank J Arena, et al.
JAMA Network Open|February 25, 2021
A Genome-First Approach to Characterize DICER1 Pathogenic Variant Prevalence, Penetrance, and PhenotypeUyenlinh L Mirshahi, Jung Kim, Ana F Best, et al.
Pageof 55